214 related articles for article (PubMed ID: 31566112)
1. Clinical and economic impact of clinical pharmacist intervention in a hematology unit.
Chen PZ; Wu CC; Huang CF
J Oncol Pharm Pract; 2020 Jun; 26(4):866-872. PubMed ID: 31566112
[TBL] [Abstract][Full Text] [Related]
2. The cost-saving effect and prevention of medication errors by clinical pharmacist intervention in a nephrology unit.
Chen CC; Hsiao FY; Shen LJ; Wu CC
Medicine (Baltimore); 2017 Aug; 96(34):e7883. PubMed ID: 28834903
[TBL] [Abstract][Full Text] [Related]
3. Clinical and economic impact of pharmacist interventions in an ambulatory hematology-oncology department.
de Grégori J; Pistre P; Boutet M; Porcher L; Devaux M; Pernot C; L Chrétien M; Rossi C; Manfredi S; Dalac S; Gueneau P; Boulin M
J Oncol Pharm Pract; 2020 Jul; 26(5):1172-1179. PubMed ID: 32299314
[TBL] [Abstract][Full Text] [Related]
4. Economic Outcomes Associated with Safety Interventions by a Pharmacist-Adjudicated Prior Authorization Consult Service.
Jacob S; Britt RB; Bryan WE; Hashem MG; Hale JC; Brown JN
J Manag Care Spec Pharm; 2019 Mar; 25(3):411-416. PubMed ID: 30816815
[TBL] [Abstract][Full Text] [Related]
5. Clinical and economic impact of medication reconciliation by designated ward pharmacists in a hospitalist-managed acute medical unit.
Park B; Baek A; Kim Y; Suh Y; Lee J; Lee E; Lee JY; Lee E; Lee J; Park HS; Kim ES; Lim Y; Kim NH; Ohn JH; Kim HW
Res Social Adm Pharm; 2022 Apr; 18(4):2683-2690. PubMed ID: 34148853
[TBL] [Abstract][Full Text] [Related]
6. Cost implications of and potential adverse events prevented by interventions of a critical care pharmacist.
Kopp BJ; Mrsan M; Erstad BL; Duby JJ
Am J Health Syst Pharm; 2007 Dec; 64(23):2483-7. PubMed ID: 18029956
[TBL] [Abstract][Full Text] [Related]
7. Impact of the clinical pharmacist interventions on prevention of pharmacotherapy related problems in the paediatric intensive care unit.
Malfará M; Pernassi M; Aragon D; Carlotti A
Int J Clin Pharm; 2018 Jun; 40(3):513-519. PubMed ID: 29603074
[TBL] [Abstract][Full Text] [Related]
8. On-ward participation of a hospital pharmacist in a Dutch intensive care unit reduces prescribing errors and related patient harm: an intervention study.
Klopotowska JE; Kuiper R; van Kan HJ; de Pont AC; Dijkgraaf MG; Lie-A-Huen L; Vroom MB; Smorenburg SM
Crit Care; 2010; 14(5):R174. PubMed ID: 20920322
[TBL] [Abstract][Full Text] [Related]
9. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
[TBL] [Abstract][Full Text] [Related]
10. Clinical and Economic Impact of Pharmacists' Intervention on Care of Pediatric Hematology and Oncology Patients.
Kim HJ; Lee S; Lee YJ; Kim S; Jo YH; Cho YS; An HY; Hong KT; Choi JY; Kang HJ; Shin HY; Lee JY
J Oncol Pharm Pract; 2023 Mar; 29(2):319-325. PubMed ID: 34931912
[TBL] [Abstract][Full Text] [Related]
11. A clinical pharmacist-led integrated approach for evaluation of medication errors among medical intensive care unit patients.
Aghili M; Neelathahalli Kasturirangan M
JBI Evid Implement; 2021 Mar; 19(1):21-30. PubMed ID: 33570331
[TBL] [Abstract][Full Text] [Related]
12. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation.
Sjölander M; Lindholm L; Pfister B; Jonsson J; Schneede J; Lövheim H; Gustafsson M
Res Social Adm Pharm; 2019 Mar; 15(3):287-291. PubMed ID: 29778344
[TBL] [Abstract][Full Text] [Related]
13. Benefit of Incorporating Clinical Pharmacists in an Adult Intensive Care Unit: A Cost-saving Study.
Muñoz-Pichuante D; Villa-Zapata L
J Clin Pharm Ther; 2020 Oct; 45(5):1127-1133. PubMed ID: 32497354
[TBL] [Abstract][Full Text] [Related]
14. Impact of medication reconciliation and review and counselling, on adverse drug events and healthcare resource use.
Al-Hashar A; Al-Zakwani I; Eriksson T; Sarakbi A; Al-Zadjali B; Al Mubaihsi S; Al Za'abi M
Int J Clin Pharm; 2018 Oct; 40(5):1154-1164. PubMed ID: 29754251
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
[TBL] [Abstract][Full Text] [Related]
16. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit.
Leape LL; Cullen DJ; Clapp MD; Burdick E; Demonaco HJ; Erickson JI; Bates DW
JAMA; 1999 Jul; 282(3):267-70. PubMed ID: 10422996
[TBL] [Abstract][Full Text] [Related]
17. Prevention of adverse drug events and cost savings associated with PharmD interventions in an academic Level I trauma center: an evidence-based approach.
Hamblin S; Rumbaugh K; Miller R
J Trauma Acute Care Surg; 2012 Dec; 73(6):1484-90. PubMed ID: 23064610
[TBL] [Abstract][Full Text] [Related]
18. Pharmacist interventions during patient rounds in two intensive care units: Clinical and financial impact.
Bosma BE; van den Bemt PMLA; Melief PHGJ; van Bommel J; Tan SS; Hunfeld NGM
Neth J Med; 2018 Apr; 76(3):115-124. PubMed ID: 29667584
[TBL] [Abstract][Full Text] [Related]
19. Evaluating the impact of telepharmacy.
Schneider PJ
Am J Health Syst Pharm; 2013 Dec; 70(23):2130-5. PubMed ID: 24249763
[TBL] [Abstract][Full Text] [Related]
20. Clinical and economic impact of pharmacists' intervention in a large volume chemotherapy preparation unit.
Han JM; Ah YM; Suh SY; Jung SH; Hahn HJ; Im SA; Lee JY
Int J Clin Pharm; 2016 Oct; 38(5):1124-32. PubMed ID: 27365091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
